Skip to Content

Progyny Inc PGNY

Morningstar Rating
$28.95 +0.77 (2.73%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PGNY is trading at a 710% premium.
Price
$28.77
Fair Value
$34.22
Uncertainty
High
1-Star Price
$42.16
5-Star Price
$53.92
Economic Moat
Xhvwpzt
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PGNY is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$28.18
Day Range
$28.3028.98
52-Week Range
$23.9044.95
Bid/Ask
$24.00 / $32.15
Market Cap
$2.76 Bil
Volume/Avg
51 / 1.2 Mil

Key Statistics

Price/Earnings (Normalized)
35.15
Price/Sales
2.64
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Small Growth
Total Number of Employees
566

Comparables

Valuation

Metric
PGNY
SPOK
ACCD
Price/Earnings (Normalized)
35.1520.67
Price/Book Value
4.871.980.63
Price/Sales
2.642.280.61
Price/Cash Flow
14.1410.0218.87
Price/Earnings
PGNY
SPOK
ACCD

Financial Strength

Metric
PGNY
SPOK
ACCD
Quick Ratio
3.251.132.62
Current Ratio
3.311.332.80
Interest Coverage
Quick Ratio
PGNY
SPOK
ACCD

Profitability

Metric
PGNY
SPOK
ACCD
Return on Assets (Normalized)
23.41%9.32%−4.92%
Return on Equity (Normalized)
33.33%12.84%−9.07%
Return on Invested Capital (Normalized)
31.71%11.47%−6.37%
Return on Assets
PGNY
SPOK
ACCD
See how this stock stacks up to its competitors with Morningstar Investor

Health Information Services Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
GE HealthCare Technologies Inc Common Stock
GEHC
YkyzjcsgQlv$36.6 Bil
Veeva Systems Inc Class A
VEEV
RlyqxvnyjXmph$30.4 Bil
Pro Medicus Ltd
PMCUF
Lqynqk$9.3 Bil
Solventum Corp
SOLV
Hhdjbt$8.5 Bil
M3 Inc
MTHRF
Hbwxjr$6.9 Bil
M3 Inc ADR
MTHRY
Cxcnnm$6.9 Bil
HealthEquity Inc
HQY
Cnqlbnk$6.7 Bil
Tempus AI Inc Class A common stock
TEM
Tbc$6.6 Bil
R1 RCM Inc
RCM
Qhr$5.3 Bil
Doximity Inc Class A
DOCS
Lqgqv$5.1 Bil

Sponsor Center